CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_3

TeraRecon DETECT

Biomarker detection and reimbursable insights

TeraRecon DETECT advances clinical and operational workflows through AI-powered biomarker detection and connected reporting.

Request a demo

Disconnected systems cost time and resources

TeraRecon DETECT optimizes imaging workflows by identifying AI biomarkers and discovering reimbursement potential

Your priority
How we deliver impact
Increased AI biomarker adoption
DETECT runs FDA-cleared biomarkers within imaging workflows, combining imaging data with patient context to ensure the appropriate biomarkers are captured for reporting and reimbursement opportunities.
A connected reimbursement workflow
With real-time tracking of study status, eligibility, prior authorization, and biomarker verification, DETECT connects clinical activity to reimbursement outcomes and supports operational decision-making.
Consistent reporting that supports collaborative care
Clinical and operational teams can work from the same system, reducing delays and improving execution. AI biomarker data helps clinical teams support more collaborative care.

Why TeraRecon DETECT?

DETECT helps healthcare providers identify opportunities to optimize reimbursement, enhance efficiency, and improve patient care

Identify eligible studies before imaging begins

Evaluate appropriateness early by combining patient context, order data, and payer requirements before and during imaging.

Run reimbursable biomarkers during imaging review

DETECT identifies relevant biomarkers from imaging and context, executes AI biomarkers during image review, and stores outputs for reporting and reimbursement potential.

Generate structured, submission-ready reports

DETECT generates structured reports during image review. Biomarker results are captured in standardized formats aligned to clinical guidelines and ready for submission.

Track reimbursement and act on performance

Use real-time status reports to quickly review reimbursement status and identify opportunities to improve your process.

Expanding portfolio of reimbursable biomarkers

TeraRecon DETECT is designed to expand the impact of imaging workflows through AI biomarkers that support more holistic patient care
DETECT plaque analysis 16 x 9

Cardiac Analysis

View and analyze cardiac CT data to identify the presence and extent of coronary plaque and heart disease
DETECT fatty liver 16 x 9

Hepatic analysis

Detects liver density measurements in contrast and non-contrast CT scans that include a significant part of the liver
DETECT Bone density 16 x 9

Bone Analysis

Detects vertebral compression fractures and measures bone mineral density in chest and abdominal CT scans
TR Detect SG.png-1

New biomarkers available through cloud deployment

New biomarkers will be added to DETECT as they are approved, enabling cloud-based access to new reimbursement workflows without additional hardware investment

Request a demo

Learn how imaging workflows can enhance patient care and uncover reimbursement possibilities

Schedule a session with a clinical visualization specialist to learn how DETECT can improve your imaging workflows.

Talk with our team

Share a few details and we will route you to the right specialist.